Quote: "The US market is hundreds of times larger than the UK market. laViv will make FCSC a successful company. You can count on that." -Don't YOU also realize that it is a "very crowded space" with more than a dozen more wrinkle and laser procedures, that will make it impossible for an under-funded micro-cap, FCSC-Laviv, with a "uber-slow" process? There is no "space among the superstars"!
I don't wanna throw salt on open wound here, but check the "pin-action" of a stock like (VVUS), that got a positive recommendation from FDA committee today and exploded; up a "whooping +78% today". And compare that to last summer when FCSC received FDA-approval for laviv and sold off and never recovered.
VVUS is set to launch a new innovative market with a "complementary product" that could make Allergan and JNJ's obesity products much more effective.
That, is how "micro-cap concerns" make their mark, pal, eh...